Trovagene, Catholic Health Initiatives deal

Trovagene and Catholic Health Initiatives’ (CHI) Center for Translational Research (CTR) subsidiary partnered to conduct clinical validation and utility studies, health economic studies and other activities to determine the effectiveness of Trovagene's urine-based cell-free (cf) DNA cancer monitoring diagnostics in clinical practice. CTR said the deal will allow it to evaluate and explore the potential to include Trovagene's cancer monitoring platform in CHI's network of hospitals. ...